Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein S6 pseudogene 1 (MRPS6P1, also referred to as MRPS6P3) is a processed pseudogene located in the human genome; it is non-coding and does not produce a functional protein. It is related to the functional MRPS6 gene, which encodes a component of the mitochondrial ribosome important for mitochondrial protein synthesis[5][1][8]. Pseudogenes like MRPS6P1 usually arise from the duplication or retrotransposition of their parental gene but accumulate mutations that render them non-functional as a protein-coding gene[1][6][8]. There is no evidence that MRPS6P1 functions as a receptor, enzyme, transporter, or therapeutic target, nor is there indication it serves as a biomarker, interacts with drugs, or is directly involved in disease processes[1][5][8]. Its main scientific importance is as a genomic feature reflecting gene duplication events and retrotransposon activity[1][8]. Occasionally pseudogenes may regulate related gene expression (e.g., as competitive endogenous RNA), but no such regulatory function has been reported for MRPS6P1[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein S6 pseudogene 1 (MRPS6P1).